杭州百誠醫藥科技股份有限公司(股票簡稱:百誠醫藥 股票代碼:301096)成立于2011年,是(shi)一家以技術開發為核(he)心的(de)綜(zong)合(he)性(xing)醫藥研發及服(fu)務公司。
公(gong)司業務涵(han)蓋藥物(wu)發現、藥學(xue)研(yan)(yan)(yan)(yan)(yan)究、臨床研(yan)(yan)(yan)(yan)(yan)究、注(zhu)冊(ce)申請等藥物(wu)研(yan)(yan)(yan)(yan)(yan)發主要環節(jie),其中在(zai)藥學(xue)研(yan)(yan)(yan)(yan)(yan)究和生物(wu)等效(xiao)性(xing)(xing)試驗(yan)(簡稱BE臨床試驗(yan))研(yan)(yan)(yan)(yan)(yan)究服務上具有核心競爭優(you)勢。公(gong)司在(zai)強化受托(tuo)研(yan)(yan)(yan)(yan)(yan)發服務能(neng)力的同(tong)時,持(chi)續加大自主研(yan)(yan)(yan)(yan)(yan)發的投入(ru)力度,實現產品(pin)開發的主導(dao)性(xing)(xing)、先(xian)進性(xing)(xing),并積(ji)極(ji)推進研(yan)(yan)(yan)(yan)(yan)發技術成果(guo)的轉化,與(yu)合(he)作伙伴共(gong)融(rong)共(gong)享。
公司(si)自創立以來高度重(zhong)視研(yan)(yan)發(fa)平(ping)臺(tai)化建(jian)設,組建(jian)多劑型開發(fa)的(de)技(ji)術中(zhong)心(xin)&平(ping)臺(tai),建(jian)有新藥物研(yan)(yan)發(fa)中(zhong)心(xin)、原料藥研(yan)(yan)究中(zhong)心(xin)、雜(za)質(zhi)研(yan)(yan)究中(zhong)心(xin)、分(fen)析(xi)測試中(zhong)心(xin)及吸入制劑、透皮給藥、緩(huan)控釋制、細粒掩(yan)味、臨床研(yan)(yan)究等技(ji)術平(ping)臺(tai),形(xing)成一系列(lie)具有自主知識產權(quan)的(de)核心(xin)技(ji)術,有力(li)支撐了公司(si)快速的(de)持(chi)續健康(kang)發(fa)展。